Medication info

Peripure 4.25% Solution

Prescription medicationSolutionInjection
Ingredient · strength
Glucose Hydrate›117.14gCalcium Chloride Hydrate›0.507gMagnesium Chloride›0.14gSodium Chloride›8.43gSodium Bicarbonate›3.29gSodium Lactate 60%›4.38g
Manufacturer / importer
Boryung BioPharma Co., Ltd.
Appearance
This medication is a pale yellow, clear peritoneal dialysis solution contained in a colorless, transparent plastic bag with two chambers.
Packaging
2L/bag (A: B = 725:1275) 3L/bag (A: B = 1087.5:1912.5)
Approval status
Active

MFDS item code 201606684 · Notified 2016.11.21 · Insurance code 670500931,670500932

Summary

Main use
Peritoneal dialysis for renal failure, detoxification of drug poisoning, and relief of discomfort from low-pH dialysate
Who receives it
Adults
Adult administration
1. The attending physician should adjust the treatment regimen, number of procedures, exchange volume, dialysis time, and duration according to the patient's symptoms. 2. This solution is used for intraperitoneal administration for dialysis treatment. 3. The dose varies according to body size, and the frequency of solution exchanges should be appropriately adjusted based on biochemical parameters and fluid-volume control. In general, 1.5 ~ 2.5L is instilled into the peritoneal cavity per exchange in adults. For continuous ambulatory peritoneal dialysis, the process of allowing the solution to dwell for 4 ~ 8 hours and then draining it is performed 3 ~ 5 times daily. For automated peritoneal dialysis, 4 ~ 5 cycles are performed overnight using a machine, and up to 2 cycles during the day. 4. When a machine is used for intermittent or continuous peritoneal dialysis, it is preferable to use bags with a volume greater than the machine's exchange volume. 5. The glucose concentration should be selected according to the patient's ultrafiltration requirements and kept as low as possible.

Ingredients

Manufacturer
Boryung BioPharma Co., Ltd.

Efficacy & effects

Peritoneal dialysis for renal failure, detoxification of drug poisoning, and relief of discomfort from low-pH dialysate

  • Acute and chronic renal failure
  • drug poisoning
  • discomfort due to low pH
View approved original text

This medication is used as a peritoneal dialysis solution for patients with acute and chronic renal failure, and is also utilized as an antidote in cases of drug poisoning where other treatments are ineffective. It also helps alleviate discomfort caused by a low pH that may occur when using lactate-based dialysis solutions. Therefore, it is used for peritoneal dialysis in renal failure patients, detoxification from drug poisoning, and improving discomfort related to dialysis solutions.

How it is given

Adult administration

1. The attending physician should adjust the treatment regimen, number of procedures, exchange volume, dialysis time, and duration according to the patient's symptoms. 2. This solution is used for intraperitoneal administration for dialysis treatment. 3. The dose varies according to body size, and the frequency of solution exchanges should be appropriately adjusted based on biochemical parameters and fluid-volume control. In general, 1.5 ~ 2.5L is instilled into the peritoneal cavity per exchange in adults. For continuous ambulatory peritoneal dialysis, the process of allowing the solution to dwell for 4 ~ 8 hours and then draining it is performed 3 ~ 5 times daily. For automated peritoneal dialysis, 4 ~ 5 cycles are performed overnight using a machine, and up to 2 cycles during the day. 4. When a machine is used for intermittent or continuous peritoneal dialysis, it is preferable to use bags with a volume greater than the machine's exchange volume. 5. The glucose concentration should be selected according to the patient's ultrafiltration requirements and kept as low as possible.

Precautions

This medication is for use in peritoneal dialysis, and discontinuing treatment early may pose a threat to life, so it must be used according to a doctor's instructions. It should not be used in patients with a perforated diaphragm, severe abdominal burns, severe peritoneal adhesion, hemorrhagic disorders, lactate metabolism disorders, or severe hypokalemia or hypocalcemia. Patients who have had recent abdominal surgery or injury, inflammatory bowel disease, abdominal fistula, intra-abdominal tumors, abdominal hernia, bowel obstruction, severe respiratory disease, sepsis, severe lipid metabolism disorders, cachexia, or significant weight loss should also avoid administration. Additionally, it is not recommended for patients who are physically or mentally unable to comply with treatment instructions. Caution should be taken when using this medication in patients taking digitalis preparations, those with glucose metabolism disorders, lumbar disorders, colostomy, diuretics users, patients with severe ventilation disorders, severe obesity, steroid users, immunocompromised patients, pregnant women, patients with peritonitis, or patients with primary hyperparathyroidism, requiring regular blood tests and monitoring. While using this medication, one must carefully monitor for possible adverse reactions such as abdominal pain, bleeding, peritonitis, inflammation around the catheter, and more. Additionally, various side effects may occur, including nausea, diarrhea, constipation, electrolyte imbalance, metabolic disorders, respiratory distress, edema, fever, muscle cramps, and blood pressure changes. Due to the risk of infection during peritoneal dialysis, it should be administered in a clean and sterile environment, and the clarity and drainage status of the dialysis solution should be continuously checked. Long-term use may lead to decreased peritoneal function, so regular checks of the patient's condition are necessary, and treatment methods should be changed as needed. This medication requires careful management of fluid balance and nutritional status, and diabetic patients should monitor their blood sugar levels frequently and adjust their insulin dosage accordingly. In case of overdose, dehydration, electrolyte abnormalities, and hyperglycemia may occur, and medical attention must be sought immediately, and the dialysis solution container should only be used if it is not damaged. Peritoneal dialysis solutions should only be used for peritoneal dialysis, and they are best used when warmed to body temperature. In children and the elderly, adjustments to dosing should be made, especially considering the risk of hernia in the elderly. The safety of this medication in pregnant or nursing women has not been established; it should only be used when the need for treatment outweighs the risks. Finally, this medication does not affect the ability to drive or operate machinery.

Side effects

Abdominal pain, bleeding, peritonitis, abdominal discomfort, cloudy drainage, fever, inflammation around the abdominal catheter, redness, discharge, catheter damage, drainage difficulties, subcutaneous inflammation, nausea, diarrhea, constipation, hemorrhoids, vomiting, loss of appetite, abdominal bloating, intestinal obstruction, hypokalemia, hyponatremia, hypocalcemia, hypophosphatemia, hyperlactatemia, hypomagnesemia, hypercholesterolemia, hypertriglyceridemia, metabolic acidosis, hypoalbuminemia, hyperglycemia, dyspnea due to diaphragmatic elevation, pulmonary edema, pleural effusion, secondary hyperparathyroidism, edema, amino acid loss, water-soluble vitamin loss, shoulder pain, muscle cramps, hernia, hydrocele, obesity, frailty, syncope, fatigue, headache, dizziness, tachycardia, hypertension, hypotension, sclerosing encapsulating peritonitis, sepsis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be kept in a sealed container to avoid contact with air, should not be frozen, and must be stored in a cool place below 25 degrees Celsius. This will help maintain the efficacy of the drug and ensure its safe use.

Appearance and packaging

Appearance

This medication is a pale yellow, clear peritoneal dialysis solution contained in a colorless, transparent plastic bag with two chambers.

Package unit

2L/bag (A: B = 725:1275) 3L/bag (A: B = 1087.5:1912.5)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.